Literature DB >> 31178247

Reduced skeletal muscle protein balance in paediatric Crohn's disease.

Amanda Davies1, Aline Nixon1, Rafeeq Muhammed2, Kostas Tsintzas1, Sian Kirkham3, Francis B Stephens4, Gordon W Moran5.   

Abstract

BACKGROUND & AIMS: An inability to respond to nutrition could be implicated in low muscle mass in Crohn's disease. We aim to determine skeletal muscle metabolic response to feeding in Crohn's disease and healthy volunteers.
METHODS: Twenty asymptomatic Crohn's disease participants (15.6 ± 0.5 yrs; BMI 20.6 ± 0.9 kg/m2); 9 with active disease (faecal calprotectin, 808 ± 225 ug/g and C-reactive protein, 2.2 ± 1.2 mg/dl), 11 in deep remission (faecal calprotectin, 61 ± 12 ug/g and C-reactive protein, 0.3 ± 0.2 mg/dl) and 9 matched healthy volunteers (16.0 ± 0.6 yrs; BMI 20.7 ± 0.6 kg/m2) were recruited. Participants had a dual energy X-ray absorptiometry scan, handgrip dynamometer test, wore a pedometer and completed a food diary. Arterialised hand and venous forearm blood samples were collected concurrently and brachial artery blood flow measured at baseline and every 20 min for 2 hrs after the ingestion of a standardised liquid meal. Net balance of branched chain amino acids (BCAA) and glucose were derived.
RESULTS: Controls had a positive mean BCAA balance. CD participants had an initial anabolic response to the meal, with increasing BCAA balance between t = 0 & t = 20, but returned to negative by t = 60. This was associated with reduced FFM z-scores in CD but not with insulin resistance or disease activity. Exploratory analyses suggest that negative postprandial BCAA response seen in CD is predominant in males (p = 0.049), with associated lower appendicular muscle mass (p = 0.034), higher muscle fatigue (p = 0.014) and reduced protein intake (p = 0.026).
CONCLUSIONS: The inability to sustain a positive protein balance postprandially could provide an explanation for the reduced muscle mass seen in CD. Further mechanistic studies will be needed to confirm these findings.
Copyright © 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Crohn's disease; Inflammatory bowel disease; Nutrition; Sarcopenia

Year:  2019        PMID: 31178247     DOI: 10.1016/j.clnu.2019.05.017

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  4 in total

1.  Wasting condition as a marker for severe disease in pediatric Crohn's disease.

Authors:  Wook Jin; Dong-Hwa Yang; Hann Tchah; Kwang-An Kwon; Jung-Ho Kim; Su-Jin Jeong; Ki-Baik Hahm
Journal:  Medicine (Baltimore)       Date:  2022-05-20       Impact factor: 1.817

2.  Sarcopenia is highly prevalent in children with autoimmune liver diseases and is linked to visceral fat and parent-perceived general health.

Authors:  Antoinette A Amevor; Toshifumi Yodoshi; Andrew T Trout; Jonathan R Dillman; Ruchi Singh; Ryan Jarvis; Lin Fei; Chunyan Liu; Amy Taylor; Alexander Miethke; Marialena Mouzaki
Journal:  Liver Int       Date:  2021-11-29       Impact factor: 8.754

3.  Prevalence of Sarcopenia and Its Effect on Postoperative Complications in Patients with Crohn's Disease.

Authors:  Chen Zhang; Dingye Yu; Liwen Hong; Tianyu Zhang; Hua Liu; Rong Fan; Lei Wang; Jie Zhong; Zhengting Wang
Journal:  Gastroenterol Res Pract       Date:  2021-09-24       Impact factor: 2.260

4.  Evaluation of bone mineral density and body compositions interrelation in young and middle-aged male patients with Crohn's disease by quantitative computed tomography.

Authors:  Xueli Zhang; Kun Peng; Gang Li; Lidi Wan; Tingting Xu; Zhijun Cui; Fuxia Xiao; Li Li; Zhanju Liu; Lin Zhang; Guangyu Tang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-23       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.